Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool.

Cibrelus L, Lingani C, Fernandez K, Djingarey MH, Perea WA, Hugonnet S.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S442-50. doi: 10.1093/cid/civ671.

2.

Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.

Cibrelus L, Medah I, Koussoubé D, Yélbeogo D, Fernandez K, Lingani C, Djingarey M, Hugonnet S.

Emerg Infect Dis. 2015 Nov;21(11):2063-6. doi: 10.3201/eid2111.150304.

3.

The development of global vaccine stockpiles.

Yen C, Hyde TB, Costa AJ, Fernandez K, Tam JS, Hugonnet S, Huvos AM, Duclos P, Dietz VJ, Burkholder BT.

Lancet Infect Dis. 2015 Mar;15(3):340-7. doi: 10.1016/S1473-3099(14)70999-5. Epub 2015 Feb 6. Review.

4.

West African Ebola epidemic after one year--slowing but not yet under control.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fraser C, Garcia E, Garske T, Hinsley W, Holmes D, Hugonnet S, Iyengar S, Jombart T, Krishnan R, Meijers S, Mills HL, Mohamed Y, Nedjati-Gilani G, Newton E, Nouvellet P, Pelletier L, Perkins D, Riley S, Sagrado M, Schnitzler J, Schumacher D, Shah A, Van Kerkhove MD, Varsaneux O, Wijekoon Kannangarage N.

N Engl J Med. 2015 Feb 5;372(6):584-7. doi: 10.1056/NEJMc1414992. Epub 2014 Dec 24. No abstract available.

5.

Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.

Collard JM, Issaka B, Zaneidou M, Hugonnet S, Nicolas P, Taha MK, Greenwood B, Jusot JF.

BMC Infect Dis. 2013 Dec 6;13:576. doi: 10.1186/1471-2334-13-576.

6.

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Daugla DM, Gami JP, Gamougam K, Naibei N, Mbainadji L, Narbé M, Toralta J, Kodbesse B, Ngadoua C, Coldiron ME, Fermon F, Page AL, Djingarey MH, Hugonnet S, Harrison OB, Rebbetts LS, Tekletsion Y, Watkins ER, Hill D, Caugant DA, Chandramohan D, Hassan-King M, Manigart O, Nascimento M, Woukeu A, Trotter C, Stuart JM, Maiden M, Greenwood BM.

Lancet. 2014 Jan 4;383(9911):40-47. doi: 10.1016/S0140-6736(13)61612-8. Epub 2013 Sep 12. Erratum in: Lancet. 2014 Jan 4;383(9911):30.

7.

Mobile microbiological laboratory support for evaluation of a meningitis epidemic in Northern Benin.

Njanpop-Lafourcade BM, Hugonnet S, Djogbe H, Kodjo A, N'douba AK, Taha MK, Stoeckel P, Gessner BD.

PLoS One. 2013 Jul 2;8(7):e68401. doi: 10.1371/journal.pone.0068401. Print 2013.

8.

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

Dakar discussion group on priorities for research on epidemic meningococcal disease in Africa, Altmann D, Aseffa A, Bash M, Basta N, Borrow R, Broome C, Caugant D, Clark T, Collard JM, Djingarey M, Goldblatt D, Greenwood B, Griffiths U, Hajjeh R, Hassan-King M, Hugonnet S, Kimball AM, LaForce M, MacLennan C, Maiden MC, Manigart O, Mayer L, Messonnier N, Moisi J, Moore K, Moto DD, Mueller J, Nascimento M, Obaro S, Ouedraogo R, Page AL, Perea W, Pluschke G, Preziosi MP, Sow S, Stephens D, Stuart J, Thomson M, Tiendrebeogo S, Trape JF, Vernet G.

Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27.

9.

A Bayesian network approach to the study of historical epidemiological databases: modelling meningitis outbreaks in the Niger.

Beresniak A, Bertherat E, Perea W, Soga G, Souley R, Dupont D, Hugonnet S.

Bull World Health Organ. 2012 Jun 1;90(6):412-417A. doi: 10.2471/BLT.11.086009. Epub 2012 Jan 20.

10.

Transmission dynamics of methicillin-resistant Staphylococcus aureus in a medical intensive care unit.

Hall IM, Barrass I, Leach S, Pittet D, Hugonnet S.

J R Soc Interface. 2012 Oct 7;9(75):2639-52. doi: 10.1098/rsif.2012.0134. Epub 2012 May 9.

11.

Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study.

Tall H, Hugonnet S, Donnen P, Dramaix-Wilmet M, Kambou L, Drabo F, Mueller JE.

BMC Infect Dis. 2012 Jan 5;12:2. doi: 10.1186/1471-2334-12-2.

12.

Pandemic potential of a strain of influenza A (H1N1): early findings.

Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Alpuche-Aranda CM, Chapela IB, Zavala EP, Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C; WHO Rapid Pandemic Assessment Collaboration.

Science. 2009 Jun 19;324(5934):1557-61. doi: 10.1126/science.1176062. Epub 2009 May 11.

13.

Staffing level: a determinant of late-onset ventilator-associated pneumonia.

Hugonnet S, Uçkay I, Pittet D.

Crit Care. 2007;11(4):R80.

14.

Liquid versus gel handrub formulation: a prospective intervention study.

Traore O, Hugonnet S, Lübbe J, Griffiths W, Pittet D.

Crit Care. 2007;11(3):R52.

15.

Community-associated methicillin-resistant Staphylococcus aureus, Switzerland.

Harbarth S, François P, Shrenzel J, Fankhauser-Rodriguez C, Hugonnet S, Koessler T, Huyghe A, Pittet D.

Emerg Infect Dis. 2005 Jun;11(6):962-5.

16.

Nosocomial bloodstream infection and clinical sepsis.

Hugonnet S, Sax H, Eggimann P, Chevrolet JC, Pittet D.

Emerg Infect Dis. 2004 Jan;10(1):76-81.

Supplemental Content

Loading ...
Support Center